Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Raises $4M in Private Placement

NEW YORK (GenomeWeb News) – Response Genetics has entered into an agreement to sell $4 million of common stock through a private placement, the Los Angeles-based molecular diagnostics firm said this week.

Response Genetics said that it had inked an agreement with certain funds managed by Lansdowne Partners to acquire 3,057,907 shares of newly issued common stock for $1.30 per share.

The firm did not provide details regarding the use of the proceeds.

Response Genetics undertook a restructuring earlier this year, in which it closed its UK facility and laid off all nine of its employees there. The firm consolidated its services at its CLIA-certified laboratory facilities in Los Angeles and planned to expand its US sales force.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.